David Katz - Matrix Advisors Value Fund 13F Activity & Position Changes (Q1 2017)

As of Mar 31, 2017, the Matrix Advisors Value Fund portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Apr 22, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2017, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q1 2017
AAPL
Apple Inc.
Sell
-4,181
Q1 2017
ABT
Abbott Laboratories
Sell - Position Exit
-6,125
Q1 2017
AMGN
Amgen Inc.
Sell - Position Exit
-3,924
Q1 2017
AXP
American Express Company
Sell
-11,043
Q1 2017
BRK-B
Berkshire Hathaway Inc. New
Buy
+190
Q1 2017
CB
Chubb Limited
Buy
+6,943
Q1 2017
CL
Colgate-Palmolive Company
Buy - Position Entry
+2,775
Q1 2017
CSCO
Cisco Systems, Inc.
Sell
-31,580
Q1 2017
CVS
CVS Health Corporation
Buy
+78,665
Q1 2017
CVX
Chevron Corporation
Sell
-4,236
Q1 2017
ETN
Eaton
Sell
-10,230
Q1 2017
GILD
Gilead Sciences, Inc.
Buy
+16,632
Q1 2017
GIS
General Mills, Inc.
Buy
+13,394
Q1 2017
GOOG
Alphabet Inc.
Buy
+1,964
Q1 2017
HOG
Harley-Davidson, Inc.
Sell
-15,826
Q1 2017
HON
Honeywell International Inc.
Sell - Position Exit
-2,150
Q1 2017
IBM
International Business Machines
Sell
-3,487
Q1 2017
IWM
iShares Russell 2000 ETF
Sell
-10
Q1 2017
JNJ
Johnson & Johnson
Buy
+3,105
Q1 2017
JPM
JP Morgan Chase & Co.
Sell
-30,426
Q1 2017
KMB
Kimberly-Clark Corporation
Buy
+2,463
Q1 2017
KO
Coca-Cola Company (The)
Buy
+7,834
Q1 2017
MCD
McDonald's Corporation
Sell
-20,466
Q1 2017
MDY
SPDR S&P MidCap 400 ETF Trust
Buy
+7
Q1 2017
MRK
Merck & Company, Inc.
Buy
+10,926
Q1 2017
MS
Morgan Stanley
Sell
-85,670
Q1 2017
MSFT
Microsoft Corporation
Sell
-17,986
Q1 2017
OXY
Occidental Petroleum Corporatio
Buy
+17,081
Q1 2017
PEP
Pepsico, Inc.
Buy
+11,221
Q1 2017
PFE
Pfizer, Inc.
Buy
+19,831
Page 1 of 2